← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2013Last known activity
Aug 6, 2018
Defunct as of Dec 31, 2020
Timeline
2010s
- Jun 8, 2011
ImmusanT, Inc.— Founded
2020s
- Dec 31, 2020
ImmusanT, Inc.— Defunct
Drugs by trial phase (2 distinct, 4 trials)
Indications
Recent trials (7)
- NCT03644069Lead sponsorPhase 2Aug 6, 2018
- NCT03644069Study chairPhase 2Aug 6, 2018
- NCT03543540Lead sponsorPhase 1May 1, 2018
- NCT03543540Study chairPhase 1May 1, 2018
- NCT02528799Study chairPhase 1Aug 1, 2015
- NCT02528799Lead sponsorPhase 1Aug 1, 2015
- NCT01932476CollaboratorN/AAug 1, 2013
Details
- Founded
- Cambridge, MA, US Jun 8, 2011
- Last known activity
- Aug 6, 2018